Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gregory T. Serfer, William J. Wheeler & Harry J. Sacks. (2010) Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm. Current Medical Research and Opinion 26:1, pages 91-99.
Read now
Read now
Articles from other publishers (15)
Yonas Getaye Tefera, Shannon Gray, Suzanne Nielsen, Asmare Gelaw & Alex Collie. (2023) Impact of Prescription Medicines on Work-Related Outcomes in Workers with Musculoskeletal Disorders or Injuries: A Systematic Scoping Review. Journal of Occupational Rehabilitation.
Crossref
Crossref
Alice Baroncini, Nicola Maffulli, Hazim Al‐Zyoud, Andreas Bell, Aleksandar Sevic & Filippo Migliorini. (2023) Nonopioid pharmacological management of acute low back pain: A level I of evidence systematic review. Journal of Orthopaedic Research 41:8, pages 1781-1791.
Crossref
Crossref
Jae-Young Hong, Kwang-Sup Song, Jae Hwan Cho, Jae Hyup Lee & Nack Hwan Kim. (2022) An Updated Overview of Low Back Pain Management. Asian Spine Journal 16:6, pages 968-982.
Crossref
Crossref
Jonathan L. Fu & Michael D. Perloff. (2022) Pharmacotherapy for Spine-Related Pain in Older Adults. Drugs & Aging 39:7, pages 523-550.
Crossref
Crossref
Aidan G Cashin, Thiago Folly, Matthew K Bagg, Michael A Wewege, Matthew D Jones, Michael C Ferraro, Hayley B Leake, Rodrigo R N Rizzo, Siobhan M Schabrun, Sylvia M Gustin, Richard Day, Christopher M Williams & James H McAuley. (2021) Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis. BMJ, pages n1446.
Crossref
Crossref
TA Lewandowski. (2016) Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults. Human & Experimental Toxicology 36:8, pages 846-853.
Crossref
Crossref
C. Abdel Shaheed, C.G. Maher, K.A. Williams & A.J. McLachlan. (2017) Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis. European Journal of Pain 21:2, pages 228-237.
Crossref
Crossref
Joseph V. Pergolizzi. 2016. Controlled Substance Management in Chronic Pain. Controlled Substance Management in Chronic Pain
111
134
.
Robert Froud, Tom Bjørkli, Philip Bright, Dévan Rajendran, Rachelle Buchbinder, Martin Underwood, David Evans & Sandra Eldridge. (2015) The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Robert I. Cohen & Carol A. Warfield. 2015. Treatment of Chronic Pain by Medical Approaches. Treatment of Chronic Pain by Medical Approaches
67
75
.
Jacques Geraets, Anne van der Linden & Mandy Kuipers. 2014. Jaarboek Fysiotherapie Kinesitherapie 2014. Jaarboek Fysiotherapie Kinesitherapie 2014
73
83
.
M.W. van Tulder & B.W. KoesM.W. van Tulder & B.W. Koes. 2013. Evidence-based handelen bij lage rugpijn. Evidence-based handelen bij lage rugpijn
69
99
.
Robert I. Cohen & Carol A. Warfield. 2013. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches
69
77
.
Julie H.Y. Huang, Haroon Hameed & Steven P. Cohen. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine
140
146
.
Steve Simon, Carrie D’Andrea, William J. Wheeler & Harry Sacks. (2010) Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study. Current Therapeutic Research 71:1, pages 50-59.
Crossref
Crossref